Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog

INTRODUCTION: Aspirin may reduce the risk of chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC) in patients receiving antiviral treatment. We aimed to investigate the impact of aspirin on reducing HCC risk in patients treated with first-line oral nucleos(t)ide analogs (NAs; entecavir a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Clin Transl Gastroenterol
Main Authors: Hui, Vicki Wing-Ki, Yip, Terry Cheuk-Fung, Wong, Vincent Wai-Sun, Tse, Yee-Kit, Chan, Henry Lik-Yuen, Lui, Grace Chung-Yan, Wong, Grace Lai-Hung
格式: Artigo
語言:Inglês
出版: Wolters Kluwer 2021
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126482/
https://ncbi.nlm.nih.gov/pubmed/33750746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000324
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍